Skip to Content

Rule

Oral Dosage Form New Animal Drugs; Change of Sponsor

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule.

SUMMARY:

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the change of sponsor for 13 new animal drug applications (NADA's) from I. D. Russell Co., Laboratories to Alpharma Inc.

DATES:

This rule is effective February 29, 2000.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Thomas J. McKay, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0213.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. D. Russell Co., Laboratories, 1301 Iowa Ave., Longmont, CO 80501, has informed FDA that it has transferred the ownership of, and all rights and interest in, the following approved NADA's to Alpharma Inc., One Executive Dr., Fort Lee, NJ 07024: Start Printed Page 10705

NADA No.Product name
6-019Zuco Poultry Tabs
6-081Korum
6-77610% Sulfaquinoxaline
6-860Ruco Tablets
6-891Liquid Sul-Q-Nox
8-902Hepasol
100-094Poultry Sulfa
100-17520% Sulfaquinoxaline
100-17634% Sulfaquinoxaline
130-435Oxytet Soluble
200-106R-Pen
200-189Lincomycin Soluble
200-274Lincomycin Injectable 30%

The agency is amending parts 510 and 520 (21 CFR parts 510 and 520) to reflect the change of sponsor. The agency is amending § 510.600(c)(1) and (c)(2) to remove the sponsor name for I. D. Russell Co., Laboratories because the firm no longer is the holder of any approved NADA's.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to congressional review requirements in 5 U.S.C 801-808.

Start List of Subjects

List of Subjects

21 CFR Part 510

  • Administrative practice and procedure
  • Animal drugs
  • Labeling
  • Reporting and recordkeeping requirements

21 CFR Part 520

  • Animal drugs
End List of Subjects

Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 520 are amended as follows:

Start Part

PART 510 NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for 21 CFR part 510 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority Start Amendment Part

2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraphs (c)(1) by removing the entry for “I. D. Russell Co., Laboratories” and in the table in paragraph (c)(2) by removing the entry for “017144”.

End Amendment Part Start Part

PART 520 ORAL DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for 21 CFR part 520 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Amended]
Start Amendment Part

4. Section 520.1263c Lincomycin hydrochloride soluble powder is amended in paragraph (b) by removing “017144” and adding in its place “046573”.

End Amendment Part
[Amended]
Start Amendment Part

5. Section 520.1660d Oxytetracycline hydrochloride soluble powder is amended in paragraphs (b)(2), (d)(1)(ii)(A)(3), (d)(1)(ii)(B)(3), (d)(1)(ii)(C)(3), and (d)(1)(iii)(C) by removing “017144” and adding in its place “046573”.

End Amendment Part
[Amended]
Start Amendment Part

6. Section 520.1696b Penicillin G potassium in drinking water is amended in paragraph (b) by removing “017144,”.

End Amendment Part
[Amended]
Start Amendment Part

7. Section 520.2088 Roxarsone tablets is amended in paragraph (c)(2) by removing “017144” and adding in its place “046573”.

End Amendment Part
[Amended]
Start Amendment Part

8. Section 520.2089 Roxarsone liquid is amended in paragraph (b) by removing “017144” and adding in its place “046573”.

End Amendment Part
[Amended]
Start Amendment Part

9. Section 520.2325a Sulfaquinoxaline drinking water is amended in paragraph (a)(3) by removing “017144” and adding in its place “046573”.

End Amendment Part Start Signature

Dated: February 16, 2000.

Claire M. Lathers,

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

End Signature End Supplemental Information

[FR Doc. 00-4668 Filed 2-28-00; 8:45 am]

BILLING CODE 4160-01-F